Align Technology, Inc. (0HCK.L)
USD 174.32
(2.38%)
USD 174.32
(2.38%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 445.05 Million USD | 23.09% |
| 2022 | 361.57 Million USD | -53.17% |
| 2021 | 772.02 Million USD | -56.53% |
| 2020 | 1.77 Billion USD | 301.08% |
| 2019 | 442.77 Million USD | 10.63% |
| 2018 | 400.23 Million USD | 72.95% |
| 2017 | 231.41 Million USD | 22.0% |
| 2016 | 189.68 Million USD | 31.71% |
| 2015 | 144.02 Million USD | -1.24% |
| 2014 | 145.83 Million USD | 126.82% |
| 2013 | 64.29 Million USD | 9.55% |
| 2012 | 58.69 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 115.96 Million USD | 20.09% |
| 2024 Q1 | 105.02 Million USD | -15.31% |
| 2024 Q2 | 96.56 Million USD | -8.06% |
| 2023 Q4 | 124.01 Million USD | 2.13% |
| 2023 FY | 445.05 Million USD | 23.09% |
| 2023 Q1 | 87.79 Million USD | 110.17% |
| 2023 Q2 | 111.81 Million USD | 27.35% |
| 2023 Q3 | 121.42 Million USD | 8.6% |
| 2022 Q4 | 41.77 Million USD | -42.54% |
| 2022 Q3 | 72.7 Million USD | -35.55% |
| 2022 FY | 361.57 Million USD | -53.17% |
| 2022 Q1 | 134.29 Million USD | -29.67% |
| 2022 Q2 | 112.8 Million USD | -16.01% |
| 2021 Q3 | 180.96 Million USD | -9.39% |
| 2021 Q4 | 190.96 Million USD | 5.52% |
| 2021 Q1 | 200.37 Million USD | 26.03% |
| 2021 Q2 | 199.71 Million USD | -0.33% |
| 2021 FY | 772.02 Million USD | -56.53% |
| 2020 Q1 | 1.51 Billion USD | 1151.94% |
| 2020 Q3 | 139.37 Million USD | 443.26% |
| 2020 FY | 1.77 Billion USD | 301.08% |
| 2020 Q4 | 158.98 Million USD | 14.08% |
| 2020 Q2 | -40.6 Million USD | -102.67% |
| 2019 FY | 442.77 Million USD | 10.63% |
| 2019 Q4 | 121.26 Million USD | 18.28% |
| 2019 Q3 | 102.52 Million USD | -30.32% |
| 2019 Q1 | 71.84 Million USD | -26.23% |
| 2019 Q2 | 147.14 Million USD | 104.8% |
| 2018 Q2 | 106.1 Million USD | 10.68% |
| 2018 Q1 | 95.86 Million USD | 834.0% |
| 2018 FY | 400.23 Million USD | 72.95% |
| 2018 Q4 | 97.39 Million USD | -3.45% |
| 2018 Q3 | 100.87 Million USD | -4.93% |
| 2017 Q4 | 10.26 Million USD | -87.57% |
| 2017 Q1 | 69.42 Million USD | 45.78% |
| 2017 FY | 231.41 Million USD | 22.0% |
| 2017 Q2 | 69.17 Million USD | -0.35% |
| 2017 Q3 | 82.55 Million USD | 19.34% |
| 2016 Q2 | 50.14 Million USD | 23.68% |
| 2016 Q1 | 40.54 Million USD | -17.04% |
| 2016 Q3 | 51.36 Million USD | 2.43% |
| 2016 FY | 189.68 Million USD | 31.71% |
| 2016 Q4 | 47.62 Million USD | -7.29% |
| 2015 Q2 | 31.35 Million USD | -13.34% |
| 2015 Q4 | 48.87 Million USD | 76.99% |
| 2015 FY | 144.02 Million USD | -1.24% |
| 2015 Q3 | 27.61 Million USD | -11.91% |
| 2015 Q1 | 36.17 Million USD | -8.51% |
| 2014 FY | 145.83 Million USD | 126.82% |
| 2014 Q2 | 35.6 Million USD | 9.73% |
| 2014 Q1 | 32.44 Million USD | -23.52% |
| 2014 Q4 | 39.54 Million USD | 3.38% |
| 2014 Q3 | 38.24 Million USD | 7.44% |
| 2013 Q2 | 29.32 Million USD | 169.84% |
| 2013 FY | 64.29 Million USD | 9.55% |
| 2013 Q1 | -41.98 Million USD | -539.2% |
| 2013 Q3 | 34.53 Million USD | 17.79% |
| 2013 Q4 | 42.42 Million USD | 22.83% |
| 2012 Q4 | 9.55 Million USD | 0.0% |
| 2012 FY | 58.69 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 425.129% |
| Accuray Incorporated | -15.54 Million USD | 2962.998% |
| Elevance Health Inc. | 5.98 Billion USD | 92.566% |
| AxoGen, Inc. | -21.71 Million USD | 2149.424% |
| Boston Scientific Corporation | 1.59 Billion USD | 72.062% |
| CVS Health Corporation | 8.34 Billion USD | 94.666% |
| Cardinal Health, Inc. | 852 Million USD | 47.764% |
| Centene Corporation | 2.7 Billion USD | 83.529% |
| DaVita Inc. | 691.53 Million USD | 35.643% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 91.51% |
| Hologic, Inc. | 789.5 Million USD | 43.628% |
| Humana Inc. | 2.48 Billion USD | 82.119% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 47.334% |
| Laboratory Corporation of America Holdings | 418 Million USD | -6.472% |
| Masimo Corporation | 81.5 Million USD | -446.077% |
| McKesson Corporation | 3 Billion USD | 85.175% |
| Patterson Companies, Inc. | 185.93 Million USD | -139.365% |
| Quest Diagnostics Incorporated | 854 Million USD | 47.886% |
| ResMed Inc. | 1.02 Billion USD | 56.408% |
| Henry Schein, Inc. | 416 Million USD | -6.984% |
| Teladoc Health, Inc. | -220.36 Million USD | 301.959% |
| Universal Health Services, Inc. | 717.79 Million USD | 37.997% |
| Veeva Systems Inc. | 525.7 Million USD | 15.342% |
| Baxter International Inc. | 2.65 Billion USD | 83.243% |
| Becton, Dickinson and Company | 1.48 Billion USD | 70.01% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 75.247% |
| Danaher Corporation | 4.2 Billion USD | 89.404% |
| Stryker Corporation | 3.16 Billion USD | 85.938% |
| Medtronic plc | 3.67 Billion USD | 87.893% |